-
1
-
-
0033984125
-
The evolving role of statins in the management of atherosclerosis
-
Vaughan, C.J., Gotto, A.M., Jr., and Basson, C.T. (2000) The evolving role of statins in the management of atherosclerosis. J. Am. Coll. Cardiol. 35, 1-10.
-
(2000)
J. Am. Coll. Cardiol
, vol.35
, pp. 1-10
-
-
Vaughan, C.J.1
Gotto Jr., A.M.2
Basson, C.T.3
-
2
-
-
0037490080
-
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: Systematic review and meta-analysis
-
Law, M.R., Wald, N.J., and Rudnicka, A.R. (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326, 1423.
-
(2003)
BMJ
, vol.326
, pp. 1423
-
-
Law, M.R.1
Wald, N.J.2
Rudnicka, A.R.3
-
3
-
-
0033596281
-
Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
-
LaRosa, J.C., He, J., and Vupputuri, S. (1999) Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 282, 2340-2346.
-
(1999)
JAMA
, vol.282
, pp. 2340-2346
-
-
LaRosa, J.C.1
He, J.2
Vupputuri, S.3
-
4
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: a randomized controlled trial
-
Schwartz, G.G., Olsson, A.G., Ezekowitz, M.D., Ganz, P., Oliver, M.F., Waters, D., Zeiher, A., Chaitman, B.R., Leslie, S., and Stern, T. (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285, 1711-1718.
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
Ganz, P.4
Oliver, M.F.5
Waters, D.6
Zeiher, A.7
Chaitman, B.R.8
Leslie, S.9
Stern, T.10
-
5
-
-
33947213317
-
Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein
-
Johnson-Anuna, L.N., Eckert, G.P., Franke, C., Igbavboa, U., Muller, W.E., and Wood, W.G. (2007) Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J. Neurochem. 101, 77-86.
-
(2007)
J. Neurochem
, vol.101
, pp. 77-86
-
-
Johnson-Anuna, L.N.1
Eckert, G.P.2
Franke, C.3
Igbavboa, U.4
Muller, W.E.5
Wood, W.G.6
-
6
-
-
0346749450
-
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity
-
Zacco, A., Togo, J., Spence, K., Ellis, A., Lloyd, D., Furlong, S., and Piser, T. (2003) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J. Neurosci. 23, 11104-11111.
-
(2003)
J. Neurosci
, vol.23
, pp. 11104-11111
-
-
Zacco, A.1
Togo, J.2
Spence, K.3
Ellis, A.4
Lloyd, D.5
Furlong, S.6
Piser, T.7
-
7
-
-
2642559507
-
Beyond the laboratory: Clinical implications for statin pleiotropy
-
Halcox, J.P. and Deanfield, J.E. (2004) Beyond the laboratory: clinical implications for statin pleiotropy. Circulation 109, II42-II48.
-
(2004)
Circulation
, vol.109
-
-
Halcox, J.P.1
Deanfield, J.E.2
-
8
-
-
34548291482
-
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
-
Li, G., Larson, E.B., Sonnen, J.A., Shofer, J.B., Petrie, E.C., Schantz, A., Peskind, E.R., Raskind, M.A., Breitner, J.C., and Montine, T.J. (2007) Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69, 878-885.
-
(2007)
Neurology
, vol.69
, pp. 878-885
-
-
Li, G.1
Larson, E.B.2
Sonnen, J.A.3
Shofer, J.B.4
Petrie, E.C.5
Schantz, A.6
Peskind, E.R.7
Raskind, M.A.8
Breitner, J.C.9
Montine, T.J.10
-
9
-
-
67649252917
-
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
-
Cramer, C., Haan, M.N., Galea, S., Langa, K.M., and Kalbfleisch, J.D. (2008) Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 71, 344-350.
-
(2008)
Neurology
, vol.71
, pp. 344-350
-
-
Cramer, C.1
Haan, M.N.2
Galea, S.3
Langa, K.M.4
Kalbfleisch, J.D.5
-
10
-
-
0030941803
-
The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
-
Brown, M.S. and Goldstein, J.L. (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89, 331-340.
-
(1997)
Cell
, vol.89
, pp. 331-340
-
-
Brown, M.S.1
Goldstein, J.L.2
-
11
-
-
0033613147
-
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
-
Brown, M.S. and Goldstein, J.L. (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. U. S. A. 96, 11041-11048.
-
(1999)
Proc. Natl. Acad. Sci. U. S. A
, vol.96
, pp. 11041-11048
-
-
Brown, M.S.1
Goldstein, J.L.2
-
12
-
-
0035843962
-
Structural mechanism for statin inhibition of HMG-CoA reductase
-
Istvan, E.S. and Deisenhofer, J. (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292, 1160-1164.
-
(2001)
Science
, vol.292
, pp. 1160-1164
-
-
Istvan, E.S.1
Deisenhofer, J.2
-
13
-
-
0035881018
-
Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins
-
Andrews, T.C., Ballantyne, C.M., Hsia, J.A., and Kramer, J.H. (2001) Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Am. J. Med. 111, 185-191.
-
(2001)
Am. J. Med
, vol.111
, pp. 185-191
-
-
Andrews, T.C.1
Ballantyne, C.M.2
Hsia, J.A.3
Kramer, J.H.4
-
14
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4s)
-
Anon
-
Anon. (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4s). Lancet 344, 1383-1389.
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
15
-
-
0036222207
-
Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs
-
Manzoni, M. and Rollini, M. (2002) Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 58, 555-564.
-
(2002)
Appl. Microbiol. Biotechnol
, vol.58
, pp. 555-564
-
-
Manzoni, M.1
Rollini, M.2
-
16
-
-
13444251203
-
Chemical, pharmacokinetic and pharmacodynamic properties of statins: An update
-
Schachter, M. (2005) Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam. Clin. Pharmacol. 19, 117-125.
-
(2005)
Fundam. Clin. Pharmacol
, vol.19
, pp. 117-125
-
-
Schachter, M.1
-
17
-
-
67449108484
-
Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk
-
Goldenberg, N. and Glueck, C. (2009) Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk. Vasc. Health Risk Manag. 5, 369-376.
-
(2009)
Vasc. Health Risk Manag
, vol.5
, pp. 369-376
-
-
Goldenberg, N.1
Glueck, C.2
-
18
-
-
0032805692
-
New insights into the pharmacodynamic and pharmacokinetic properties of statins
-
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., and Bernini, F. (1999) New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 84, 413-428.
-
(1999)
Pharmacol. Ther
, vol.84
, pp. 413-428
-
-
Corsini, A.1
Bellosta, S.2
Baetta, R.3
Fumagalli, R.4
Paoletti, R.5
Bernini, F.6
-
19
-
-
33847099636
-
Predicting the oxidative metabolism of statins: An application of the MetaSite algorithm
-
Caron, G., Ermondi, G., and Testa, B. (2007) Predicting the oxidative metabolism of statins: an application of the MetaSite algorithm. Pharm. Res. 24, 480-501.
-
(2007)
Pharm. Res
, vol.24
, pp. 480-501
-
-
Caron, G.1
Ermondi, G.2
Testa, B.3
-
20
-
-
0037319739
-
Statin effects beyond lipid-lowering - are they clinically relevant?
-
Bonetti, P.O., Lerman, L.O., Napoli, C., and Lerman, A. (2003) Statin effects beyond lipid-lowering - are they clinically relevant? Eur. Heart J. 24, 225-248.
-
(2003)
Eur. Heart J
, vol.24
, pp. 225-248
-
-
Bonetti, P.O.1
Lerman, L.O.2
Napoli, C.3
Lerman, A.4
-
21
-
-
23944445364
-
Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol
-
Liao, J.K. (2005) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am. J. Cardiol. 96, 24F-33F.
-
(2005)
Am. J. Cardiol
, vol.96
-
-
Liao, J.K.1
-
22
-
-
0033117022
-
Pravastatin therapy in hyperlipidemia: Effects on thrombus formation and the systemic hemostatic profile
-
Dangas, G., Badimon, J.J., Smith, D.A., Unger, A.H., Levine, D., Shao, J.H., Meraj, P., Fier, C., Fallon, J.T., and Ambrose, J.A. (1999) Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J. Am. Coll. Cardiol. 33, 1294-1304.
-
(1999)
J. Am. Coll. Cardiol
, vol.33
, pp. 1294-1304
-
-
Dangas, G.1
Badimon, J.J.2
Smith, D.A.3
Unger, A.H.4
Levine, D.5
Shao, J.H.6
Meraj, P.7
Fier, C.8
Fallon, J.T.9
Ambrose, J.A.10
-
23
-
-
0035192759
-
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits
-
Rikitake, Y., Kawashima, S., Takeshita, S., Yamashita, T., Azumi, H., Yasuhara, M., Nishi, H., Inoue, N., and Yokoyama, M. (2001) Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 154, 87-96.
-
(2001)
Atherosclerosis
, vol.154
, pp. 87-96
-
-
Rikitake, Y.1
Kawashima, S.2
Takeshita, S.3
Yamashita, T.4
Azumi, H.5
Yasuhara, M.6
Nishi, H.7
Inoue, N.8
Yokoyama, M.9
-
24
-
-
0033586472
-
Inhibition of proinflammatory cytokine production by pravastatin
-
Rosenson, R.S., Tangney, C.C., and Casey, L.C. (1999) Inhibition of proinflammatory cytokine production by pravastatin. Lancet 353, 983-984.
-
(1999)
Lancet
, vol.353
, pp. 983-984
-
-
Rosenson, R.S.1
Tangney, C.C.2
Casey, L.C.3
-
25
-
-
0036633659
-
A 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall
-
Nagashima, H., Aoka, Y., Sakomura, Y., Sakuta, A., Aomi, S., Ishizuka, N., Hagiwara, N., Kawana, M., and Kasanuki, H. (2002) A 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J. Vasc. Surg. 36, 158-163.
-
(2002)
J. Vasc. Surg
, vol.36
, pp. 158-163
-
-
Nagashima, H.1
Aoka, Y.2
Sakomura, Y.3
Sakuta, A.4
Aomi, S.5
Ishizuka, N.6
Hagiwara, N.7
Kawana, M.8
Kasanuki, H.9
-
26
-
-
18444364236
-
Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis
-
Arnaud, C., Veillard, N.R., and Mach, F. (2005) Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Curr. Drug Targets 5, 127-134.
-
(2005)
Curr. Drug Targets
, vol.5
, pp. 127-134
-
-
Arnaud, C.1
Veillard, N.R.2
Mach, F.3
-
27
-
-
16344370063
-
Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases
-
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P.E., Capecchi, P.L., Pasini, F.L., and Baldari, C.T. (2005) Simvastatin inhibits T-cell activation by selectively impairing the function of Ras superfamily GTPases. FASEB J. 19, 605-607.
-
(2005)
FASEB J
, vol.19
, pp. 605-607
-
-
Ghittoni, R.1
Patrussi, L.2
Pirozzi, K.3
Pellegrini, M.4
Lazzerini, P.E.5
Capecchi, P.L.6
Pasini, F.L.7
Baldari, C.T.8
-
28
-
-
41749108172
-
In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin
-
Ajith, T.A., Riji, T., and Anu, V. (2008) In vitro anti-oxidant and DNA protective effects of the novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin. Clin. Exp. Pharmacol. Physiol. 35, 625-629.
-
(2008)
Clin. Exp. Pharmacol. Physiol
, vol.35
, pp. 625-629
-
-
Ajith, T.A.1
Riji, T.2
Anu, V.3
-
29
-
-
0031050342
-
Reduced susceptibility of LDL to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL
-
Hussein, O., Schlezinger, S., and Rosenblat, M. (1997) Reduced susceptibility of LDL to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. Atherosclerosis 128, 11-18.
-
(1997)
Atherosclerosis
, vol.128
, pp. 11-18
-
-
Hussein, O.1
Schlezinger, S.2
Rosenblat, M.3
-
30
-
-
0027492038
-
Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte derived macrophages
-
Giroux, L.M., Davignon, J., and Naruszewicz, M. (1993) Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte derived macrophages. Biochim. Biophys. Acta 1165, 335-338.
-
(1993)
Biochim. Biophys. Acta
, vol.1165
, pp. 335-338
-
-
Giroux, L.M.1
Davignon, J.2
Naruszewicz, M.3
-
31
-
-
0033002575
-
Simvastatin decreases aldehyde production derived from lipoprotein oxidation
-
Girona, J., La Ville, A.E., and Sola, R. (1999) Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am. J. Cardiol. 83, 846-851.
-
(1999)
Am. J. Cardiol
, vol.83
, pp. 846-851
-
-
Girona, J.1
La Ville, A.E.2
Sola, R.3
-
32
-
-
0025120211
-
Regulation of the mevalonate pathway
-
Goldstein, J.L. and Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature 343, 425-430.
-
(1990)
Nature
, vol.343
, pp. 425-430
-
-
Goldstein, J.L.1
Brown, M.S.2
-
33
-
-
0029898894
-
Protein prenylation: Molecular mechanisms and functional consequences
-
Zhang, F.L. and Casey, P.J. (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65, 241-269.
-
(1996)
Annu. Rev. Biochem
, vol.65
, pp. 241-269
-
-
Zhang, F.L.1
Casey, P.J.2
-
34
-
-
34347369084
-
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
-
Konstantinopoulos, P.A., Karamouzis, M.V., and Papavassiliou, A.G. (2007) Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat. Rev. Drug Discov. 6, 541-555.
-
(2007)
Nat. Rev. Drug Discov
, vol.6
, pp. 541-555
-
-
Konstantinopoulos, P.A.1
Karamouzis, M.V.2
Papavassiliou, A.G.3
-
35
-
-
56149098127
-
Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition
-
Chen, W., Pendyala, S., Natarajan, V., Garcia, J.G., and Jacobson, J.R. (2008) Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L575-L583.
-
(2008)
Am. J. Physiol. Lung Cell. Mol. Physiol
, vol.295
-
-
Chen, W.1
Pendyala, S.2
Natarajan, V.3
Garcia, J.G.4
Jacobson, J.R.5
-
36
-
-
0032557526
-
Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases
-
Montaner, S., Perona, R., Saniger, L., and Lacal, J.C. (1998) Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases. J. Biol. Chem. 273, 12779-12785.
-
(1998)
J. Biol. Chem
, vol.273
, pp. 12779-12785
-
-
Montaner, S.1
Perona, R.2
Saniger, L.3
Lacal, J.C.4
-
37
-
-
26644442350
-
Mechanisms of statinmediated inhibition of small G-protein function
-
Cordle, A., Koenigsknecht-Talboo, J., Wilkinson, B., Limpert, A., and Landreth, G. (2005) Mechanisms of statinmediated inhibition of small G-protein function. J. Biol. Chem. 280, 34202-34209.
-
(2005)
J. Biol. Chem
, vol.280
, pp. 34202-34209
-
-
Cordle, A.1
Koenigsknecht-Talboo, J.2
Wilkinson, B.3
Limpert, A.4
Landreth, G.5
-
38
-
-
34347343830
-
Impact of HMG-CoA reductase inhibition on brain pathology
-
Zipp, F., Waiczies, S., Aktas, O., Neuhaus, O., Hemmer, B., Schraven, B., Nitsch, R., and Hartung, H.P. (2007) Impact of HMG-CoA reductase inhibition on brain pathology. Trends Pharmacol. Sci. 28, 342-349.
-
(2007)
Trends Pharmacol. Sci
, vol.28
, pp. 342-349
-
-
Zipp, F.1
Waiczies, S.2
Aktas, O.3
Neuhaus, O.4
Hemmer, B.5
Schraven, B.6
Nitsch, R.7
Hartung, H.P.8
-
39
-
-
2342640996
-
Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin
-
Jacobson, J.R., Dudek, S.M., Birukov, K.G., Ye, S.Q., Grigoryev, D.N., Girgis, R.E., and Garcia, J.G. (2004) Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am. J. Respir. Cell Mol. Biol. 30, 662-670.
-
(2004)
Am. J. Respir. Cell Mol. Biol
, vol.30
, pp. 662-670
-
-
Jacobson, J.R.1
Dudek, S.M.2
Birukov, K.G.3
Ye, S.Q.4
Grigoryev, D.N.5
Girgis, R.E.6
Garcia, J.G.7
-
40
-
-
36349023095
-
Epinephrine regulation of the endothelial nitric-oxide synthase: Roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling
-
Kou, R. and Michel, T. (2007) Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. J. Biol. Chem. 282, 32719-32729.
-
(2007)
J. Biol. Chem
, vol.282
, pp. 32719-32729
-
-
Kou, R.1
Michel, T.2
-
41
-
-
27644469148
-
Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension
-
Bayorh, M.A., Ganafa, A.A., Eatman, D., Walton, M., and Feuerstein, G.Z. (2005) Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am. J. Hypertens. 18, 1496-1502.
-
(2005)
Am. J. Hypertens
, vol.18
, pp. 1496-1502
-
-
Bayorh, M.A.1
Ganafa, A.A.2
Eatman, D.3
Walton, M.4
Feuerstein, G.Z.5
-
42
-
-
0033802611
-
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
-
Park, J.K., Muller, D.N., Mervaala, E.M., Dechend, R., Fiebeler, A., Schmidt, F., Bieringer, M., Schafer, O., Lindschau, C., Schneider, W., Ganten, D., Luft, F.C., and Haller, H. (2000) Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int. 58, 1420-1430.
-
(2000)
Kidney Int
, vol.58
, pp. 1420-1430
-
-
Park, J.K.1
Muller, D.N.2
Mervaala, E.M.3
Dechend, R.4
Fiebeler, A.5
Schmidt, F.6
Bieringer, M.7
Schafer, O.8
Lindschau, C.9
Schneider, W.10
Ganten, D.11
Luft, F.C.12
Haller, H.13
-
43
-
-
0035122832
-
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: Involvement of angiotensin AT1 receptor expression and Rac1 GTPase
-
Wassmann, S., Laufs, U., Baumer, A.T., Muller, K., Konkol, C., Sauer, H., Bohm, M., and Nickenig, G. (2001) Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol. Pharmacol. 59, 646-654.
-
(2001)
Mol. Pharmacol
, vol.59
, pp. 646-654
-
-
Wassmann, S.1
Laufs, U.2
Baumer, A.T.3
Muller, K.4
Konkol, C.5
Sauer, H.6
Bohm, M.7
Nickenig, G.8
-
44
-
-
0035571607
-
Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells
-
Ichiki, T., Takeda, K., Tokunou, T., Iino, N., Egashira, K., Shimokawa, H., Hirano, K., Kanaide, H., and Takeshita, A. (2001) Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21, 1896-1901.
-
(2001)
Arterioscler. Thromb. Vasc. Biol
, vol.21
, pp. 1896-1901
-
-
Ichiki, T.1
Takeda, K.2
Tokunou, T.3
Iino, N.4
Egashira, K.5
Shimokawa, H.6
Hirano, K.7
Kanaide, H.8
Takeshita, A.9
-
45
-
-
34247093334
-
Nitric oxide and the vascular endothelium
-
Moncada, S. and Higgs, E.A. (2006) Nitric oxide and the vascular endothelium. Handb. Exp. Pharmacol. 176, 213-254.
-
(2006)
Handb. Exp. Pharmacol
, vol.176
, pp. 213-254
-
-
Moncada, S.1
Higgs, E.A.2
-
46
-
-
33749433931
-
The many antithrombotic actions of nitric oxide
-
Tziros, C. and Freedman, J.E. (2006) The many antithrombotic actions of nitric oxide. Curr. Drug Targets 7, 1243-1251.
-
(2006)
Curr. Drug Targets
, vol.7
, pp. 1243-1251
-
-
Tziros, C.1
Freedman, J.E.2
-
47
-
-
0037304922
-
Endothelial nitric oxide synthase: The Cinderella of inflammation?
-
Cirino, G., Fiorucci, S., and Sessa, W.C. (2003) Endothelial nitric oxide synthase: the Cinderella of inflammation? Trends Pharmacol. Sci. 24, 91-95.
-
(2003)
Trends Pharmacol. Sci
, vol.24
, pp. 91-95
-
-
Cirino, G.1
Fiorucci, S.2
Sessa, W.C.3
-
48
-
-
0032910873
-
Nitric oxide. I. Physiological .chemistry of nitric oxide and its metabolites: Implications in inflammation
-
Grisham, M.B., Jourd'Heuil, D., and Wink, D.A. (1999) Nitric oxide. I. Physiological .chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 276, G315-G321.
-
(1999)
Am. J. Physiol. Gastrointest. Liver Physiol
, vol.276
-
-
Grisham, M.B.1
Jourd'Heuil, D.2
Wink, D.A.3
-
49
-
-
0035312651
-
Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks
-
John, S., Delles, C., Jacobi, J., Schlaich, M.P., Schneider, M., Schmitz, G., and Schmieder, R.E. (2001) Rapid improvement of nitric oxide bioavailability after lipid-lowering therapy with cerivastatin within two weeks. J. Am. Coll. Cardiol. 37, 1351-1358.
-
(2001)
J. Am. Coll. Cardiol
, vol.37
, pp. 1351-1358
-
-
John, S.1
Delles, C.2
Jacobi, J.3
Schlaich, M.P.4
Schneider, M.5
Schmitz, G.6
Schmieder, R.E.7
-
50
-
-
0035726268
-
3-Hydroxy-3- methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells
-
Kolyada, A.Y., Fedtsov, A., and Madias, N.E. (2001) 3-Hydroxy-3- methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. Hypertension 38, 1024-1029.
-
(2001)
Hypertension
, vol.38
, pp. 1024-1029
-
-
Kolyada, A.Y.1
Fedtsov, A.2
Madias, N.E.3
-
51
-
-
0033664617
-
Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells
-
Chen, H., Ikeda, U., Shimpo, M., Ikeda, M., Minota, S., and Shimada, K. (2000) Fluvastatin upregulates inducible nitric oxide synthase expression in cytokine-stimulated vascular smooth muscle cells. Hypertension 36, 923-928.
-
(2000)
Hypertension
, vol.36
, pp. 923-928
-
-
Chen, H.1
Ikeda, U.2
Shimpo, M.3
Ikeda, M.4
Minota, S.5
Shimada, K.6
-
52
-
-
33644694919
-
Rho GTPases, statins, and nitric oxide
-
Rikitake, Y. and Liao, J.K. (2005) Rho GTPases, statins, and nitric oxide. Circ. Res. 97, 1232-1235.
-
(2005)
Circ. Res
, vol.97
, pp. 1232-1235
-
-
Rikitake, Y.1
Liao, J.K.2
-
53
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M.A., and Liao, J.K. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 95, 8880-8885.
-
(1998)
Proc. Natl. Acad. Sci. U. S. A
, vol.95
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, T.4
Huang, P.5
Moskowitz, M.A.6
Liao, J.K.7
-
54
-
-
0033800718
-
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
-
Laufs, U., Gertz, K., Huang, P., Nickenig, G., Bohm, M., Dirnagl, U., and Endres, M. (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31, 2442-2449.
-
(2000)
Stroke
, vol.31
, pp. 2442-2449
-
-
Laufs, U.1
Gertz, K.2
Huang, P.3
Nickenig, G.4
Bohm, M.5
Dirnagl, U.6
Endres, M.7
-
55
-
-
0034006811
-
Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by l-arginine after chronic statin treatment
-
Yamada, M., Huang, Z., Dalkara, T., Endres, M., Laufs, U., Waeber, C., Huang, P.L., Liao, J.K., and Moskowitz, M.A. (2000) Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by l-arginine after chronic statin treatment. J. Cereb. Blood Flow Metab. 20, 709-717.
-
(2000)
J. Cereb. Blood Flow Metab
, vol.20
, pp. 709-717
-
-
Yamada, M.1
Huang, Z.2
Dalkara, T.3
Endres, M.4
Laufs, U.5
Waeber, C.6
Huang, P.L.7
Liao, J.K.8
Moskowitz, M.A.9
-
56
-
-
0032757209
-
Atorvastatin reduces NF- B activation and chemokine expression in vascular smooth muscle cells and mononuclear cells
-
Ortego, M., Bustos, C., Hernandez-Presa, M.A., Tunon, J., Diaz, C., Hernandez, G., and Egido, J. (1999) Atorvastatin reduces NF- B activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147, 253-261.
-
(1999)
Atherosclerosis
, vol.147
, pp. 253-261
-
-
Ortego, M.1
Bustos, C.2
Hernandez-Presa, M.A.3
Tunon, J.4
Diaz, C.5
Hernandez, G.6
Egido, J.7
-
57
-
-
0036430006
-
Direct in vivo evidence of a vascular statin: A single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects
-
Omori, H., Nagashima, H., Tsurumi, Y., Takagi, A., Ishizuka, N., Hagiwara, N., Kawana, M., and Kasanuki, H. (2002) Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects. Br. J. Clin. Pharmacol. 54, 395-399.
-
(2002)
Br. J. Clin. Pharmacol
, vol.54
, pp. 395-399
-
-
Omori, H.1
Nagashima, H.2
Tsurumi, Y.3
Takagi, A.4
Ishizuka, N.5
Hagiwara, N.6
Kawana, M.7
Kasanuki, H.8
-
58
-
-
0032753626
-
Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects
-
Tannous, M., Cheung, R., Vignini, A., and Mutus, B. (1999) Atorvastatin increases ecNOS levels in human platelets of hyperlipidemic subjects. Thromb. Haemost. 82, 1390-1394.
-
(1999)
Thromb. Haemost
, vol.82
, pp. 1390-1394
-
-
Tannous, M.1
Cheung, R.2
Vignini, A.3
Mutus, B.4
-
59
-
-
49949086299
-
Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels
-
Yemisci, M., Ay, H., Kocaefe, C., Qui, J., Topalkara, K., Ozgüç, M., Kirazli, S., Ozcebe, O., Moskowitz, M.A., and Dalkara, T. (2008) Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovasc. Dis. 26, 190-198.
-
(2008)
Cerebrovasc. Dis
, vol.26
, pp. 190-198
-
-
Yemisci, M.1
Ay, H.2
Kocaefe, C.3
Qui, J.4
Topalkara, K.5
Ozgüç, M.6
Kirazli, S.7
Ozcebe, O.8
Moskowitz, M.A.9
Dalkara, T.10
-
60
-
-
15944377914
-
Treatment with statins in the acute phase of ischemic stroke
-
Montaner, J. (2005) Treatment with statins in the acute phase of ischemic stroke. Expert Rev. Neurother. 5, 211-221.
-
(2005)
Expert Rev. Neurother
, vol.5
, pp. 211-221
-
-
Montaner, J.1
-
61
-
-
33646167277
-
Neuroprotective properties of statins
-
Stêpieñ, K., Tomaszewski, M., and Czuczwar, S.J. (2005) Neuroprotective properties of statins. Pharmacol. Rep. 57, 561-569.
-
(2005)
Pharmacol. Rep
, vol.57
, pp. 561-569
-
-
Stêpieñ, K.1
Tomaszewski, M.2
Czuczwar, S.J.3
-
62
-
-
65049089153
-
Statins: Mechanisms of neuroprotection
-
van der Most, P.J., Dolga, A.M., Nijholt, I.M., Luiten, P.G., and Eisel, U.L. (2009) Statins: mechanisms of neuroprotection. Prog. Neurobiol. 88, 64-75.
-
(2009)
Prog. Neurobiol
, vol.88
, pp. 64-75
-
-
van der Most, P.J.1
Dolga, A.M.2
Nijholt, I.M.3
Luiten, P.G.4
Eisel, U.L.5
-
63
-
-
0042023711
-
Alzheimer's disease in the US population: Prevalence estimates using the 2000 census
-
Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennet, D.A., and Evans, D.A. (2003) Alzheimer's disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60, 1119-1122.
-
(2003)
Arch. Neurol
, vol.60
, pp. 1119-1122
-
-
Hebert, L.E.1
Scherr, P.A.2
Bienias, J.L.3
Bennet, D.A.4
Evans, D.A.5
-
64
-
-
0034049944
-
Proteolytic processing and cell biological functions of the amyloid precursor protein
-
De Strooper, B. and Annaert, W. (2000) Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113, 1857-1870.
-
(2000)
J. Cell Sci
, vol.113
, pp. 1857-1870
-
-
De Strooper, B.1
Annaert, W.2
-
65
-
-
0026646604
-
Amyloid beta-peptide is produced by cultured cells during normal metabolism
-
Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Koo, E.H., Schenk, D., Teplow, D.B., and Selkoe, D.J. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
-
(1992)
Nature
, vol.359
, pp. 322-325
-
-
Haass, C.1
Schlossmacher, M.G.2
Hung, A.Y.3
Vigo-Pelfrey, C.4
Mellon, A.5
Ostaszewski, B.L.6
Lieberburg, I.7
Koo, E.H.8
Schenk, D.9
Teplow, D.B.10
Selkoe, D.J.11
-
66
-
-
57649221135
-
Amyloid precursor protein trafficking, processing, and function
-
Thinakaran, G. and Koo, E.H. (2008). Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 283, 29615-29619.
-
(2008)
J. Biol. Chem
, vol.283
, pp. 29615-29619
-
-
Thinakaran, G.1
Koo, E.H.2
-
67
-
-
0029844205
-
Human apolipoprotein E: The Alzheimer's disease connection
-
Weisgraber, K.H. and Mahley, R.W. (1996) Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10, 1485-1494.
-
(1996)
FASEB J
, vol.10
, pp. 1485-1494
-
-
Weisgraber, K.H.1
Mahley, R.W.2
-
68
-
-
0027282035
-
Apolipoprotein E polymorphism and Alzheimer's disease
-
Poirier, J., Davignon, J., Bouthillier, D., Kogan, S., Bertrand, P., and Gauthier, S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
-
(1993)
Lancet
, vol.342
, pp. 697-699
-
-
Poirier, J.1
Davignon, J.2
Bouthillier, D.3
Kogan, S.4
Bertrand, P.5
Gauthier, S.6
-
69
-
-
0027194791
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
-
Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., and Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
Schmechel, D.E.4
Gaskell, P.C.5
Small, G.W.6
Roses, A.D.7
Haines, J.L.8
Pericak-Vance, M.A.9
-
70
-
-
23744505013
-
ApoE alleles and tau markers in patients with different levels of cognitive impairment
-
Lavados, M., Farias, G., Rothhammer, F., Guillon, M., Mujica, M.C., Maccioni, C., and Maccioni, R.B. (2005) ApoE alleles and tau markers in patients with different levels of cognitive impairment. Arch. Med. Res. 36, 474-479.
-
(2005)
Arch. Med. Res
, vol.36
, pp. 474-479
-
-
Lavados, M.1
Farias, G.2
Rothhammer, F.3
Guillon, M.4
Mujica, M.C.5
Maccioni, C.6
Maccioni, R.B.7
-
71
-
-
33745739157
-
Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: Results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial
-
Sparks, D.L., Connor, D.J., Sabbagh, M.N., Petersen, R.B., Lopez, J., and Browne, P. (2006) Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. Acta Neurol. Scand. 185, 3-7.
-
(2006)
Acta Neurol. Scand
, vol.185
, pp. 3-7
-
-
Sparks, D.L.1
Connor, D.J.2
Sabbagh, M.N.3
Petersen, R.B.4
Lopez, J.5
Browne, P.6
-
72
-
-
35748971011
-
Prospective Study of Pravastatin in the Elderly at Risk Group (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults
-
Packard, C.J., Westendorp, R.G., Stott, D.J., Caslake, M.J., Murray, H.M., Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., Ford, I., Gaw, A., Hyland, M., Jukema, J.W., Kamper, A.M., Macfarlane, P.W., Jolles, J., Perry, I.J., Sweeney, B.J., and Twomey, C.; Prospective Study of Pravastatin in the Elderly at Risk Group (2007) Association between apolipoprotein E4 and cognitive decline in elderly adults. J. Am. Geriatr. Soc. 55, 1777-1785.
-
(1777)
J. Am. Geriatr. Soc
, vol.55
-
-
Packard, C.J.1
Westendorp, R.G.2
Stott, D.J.3
Caslake, M.J.4
Murray, H.M.5
Shepherd, J.6
Blauw, G.J.7
Murphy, M.B.8
Bollen, E.L.9
Buckley, B.M.10
Cobbe, S.M.11
Ford, I.12
Gaw, A.13
Hyland, M.14
Jukema, J.W.15
Kamper, A.M.16
Macfarlane, P.W.17
Jolles, J.18
Perry, I.J.19
Sweeney, B.J.20
Twomey, C.21
more..
-
73
-
-
77649104296
-
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
-
Epub ahead of print
-
Trompet, S., van Vliet, P., de Craen, A.J., Jolles, J., Buckley, B.M., Murphy, M.B., Ford, I., Macfarlane, P.W., Sattar, N., Packard, C.J., Stott, D.J., Shepherd, J., Bollen, E.L., Blauw, G.J., Jukema, J.W., and Westendorp, R.G. (2009) Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J. Neurol. [Epub ahead of print]
-
(2009)
J. Neurol
-
-
Trompet, S.1
van Vliet, P.2
de Craen, A.J.3
Jolles, J.4
Buckley, B.M.5
Murphy, M.B.6
Ford, I.7
Macfarlane, P.W.8
Sattar, N.9
Packard, C.J.10
Stott, D.J.11
Shepherd, J.12
Bollen, E.L.13
Blauw, G.J.14
Jukema, J.W.15
Westendorp, R.G.16
-
74
-
-
57549113510
-
A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets
-
Liu, W.W., Todd, S., Coulson, D.T., Irvine, G.B., Passmore, A.P., McGuinness, B., McConville, M., Craig, D., and Johnston, J.A. (2009) A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets. J. Neurochem. 108, 341-349.
-
(2009)
J. Neurochem
, vol.108
, pp. 341-349
-
-
Liu, W.W.1
Todd, S.2
Coulson, D.T.3
Irvine, G.B.4
Passmore, A.P.5
McGuinness, B.6
McConville, M.7
Craig, D.8
Johnston, J.A.9
-
75
-
-
0037421206
-
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
-
Ehehalt, R., Keller, P., Haass, C., Thiele, C., and Simons, K. (2003) Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160, 113-123.
-
(2003)
J. Cell Biol
, vol.160
, pp. 113-123
-
-
Ehehalt, R.1
Keller, P.2
Haass, C.3
Thiele, C.4
Simons, K.5
-
76
-
-
0032568552
-
Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons
-
Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., and Simons, K. (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U. S. A. 95, 6460-6464.
-
(1998)
Proc. Natl. Acad. Sci. U. S. A
, vol.95
, pp. 6460-6464
-
-
Simons, M.1
Keller, P.2
De Strooper, B.3
Beyreuther, K.4
Dotti, C.G.5
Simons, K.6
-
77
-
-
0036180950
-
Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains
-
Wahrle, S., Das, P., Nyborg, A.C., McLendon, C., Shoji, M., Kawarabayashi, T., Younkin, L.H., Younkin, S.G., and Golde, T.E. (2002) Cholesterol-dependent gamma-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9, 11-23.
-
(2002)
Neurobiol. Dis
, vol.9
, pp. 11-23
-
-
Wahrle, S.1
Das, P.2
Nyborg, A.C.3
McLendon, C.4
Shoji, M.5
Kawarabayashi, T.6
Younkin, L.H.7
Younkin, S.G.8
Golde, T.E.9
-
78
-
-
45549093275
-
Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels
-
Grimm, M.O., Grimm, H.S., Tomic, I., Beyreuther, K., Hartmann, T., and Bergmann, C. (2008) Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J. Biol. Chem. 283, 11302-11311.
-
(2008)
J. Biol. Chem
, vol.283
, pp. 11302-11311
-
-
Grimm, M.O.1
Grimm, H.S.2
Tomic, I.3
Beyreuther, K.4
Hartmann, T.5
Bergmann, C.6
-
79
-
-
0029671454
-
Cholesterol modulates α-secretase cleavage of amyloid precursor protein
-
Bodovitz, S. and Klein, W.L. (1996) Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 271, 4436-4440.
-
(1996)
J. Biol. Chem
, vol.271
, pp. 4436-4440
-
-
Bodovitz, S.1
Klein, W.L.2
-
80
-
-
0035826909
-
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10
-
Kojro, E., Gimple, G., Lammich, S., März, W., and Fahrenholz, F. (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha-secretase ADAM 10. Proc. Natl. Acad. Sci. U. S. A. 98, 5815-5820.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A
, vol.98
, pp. 5815-5820
-
-
Kojro, E.1
Gimple, G.2
Lammich, S.3
März, W.4
Fahrenholz, F.5
-
81
-
-
0001504829
-
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo
-
Fassbender, K., Simons, M., Bergmann, C., Stroick, M., Lutjohann, D., Keller, P., Runz, H., Kuhl, S., Bertsch, T., von Bergmann, K., Hennerici, M., Bevreuther, K., and Hartmann, T. (2001) Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 98, 5856-5861.
-
(2001)
Proc. Natl. Acad. Sci. U. S. A
, vol.98
, pp. 5856-5861
-
-
Fassbender, K.1
Simons, M.2
Bergmann, C.3
Stroick, M.4
Lutjohann, D.5
Keller, P.6
Runz, H.7
Kuhl, S.8
Bertsch, T.9
von Bergmann, K.10
Hennerici, M.11
Bevreuther, K.12
Hartmann, T.13
-
82
-
-
0036550239
-
Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer -amyloid peptide in vitro and in patients
-
Buxbaum, J.D., Cullen, E.I., and Friedhoff, L.T. (2002) Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer -amyloid peptide in vitro and in patients. Front. Biosci. 7, a50-a59.
-
(2002)
Front. Biosci
, vol.7
-
-
Buxbaum, J.D.1
Cullen, E.I.2
Friedhoff, L.T.3
-
83
-
-
4143063543
-
Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
-
Parvathy, S., Ehrlich, M., Pedrini, S., Diaz, N., Refolo, L., Buxbaum, J.D., Bogush, A., Petanceska, S., and Gandy, S. (2004) Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. J. Neurochem. 90, 1005-1010.
-
(2004)
J. Neurochem
, vol.90
, pp. 1005-1010
-
-
Parvathy, S.1
Ehrlich, M.2
Pedrini, S.3
Diaz, N.4
Refolo, L.5
Buxbaum, J.D.6
Bogush, A.7
Petanceska, S.8
Gandy, S.9
-
84
-
-
33745235789
-
Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin
-
Gellermann, G.P., Ullrich, K., Tannert, A., Unger, C., Habicht, G., Sauter, S.R., Hortschansky, P., Horn, U., Mollmann, U., Decker, M., Lehmann, J., and Fandrich, M. (2006) Alzheimer-like plaque formation by human macrophages is reduced by fibrillation inhibitors and lovastatin. J. Mol. Biol. 360, 251-257.
-
(2006)
J. Mol. Biol
, vol.360
, pp. 251-257
-
-
Gellermann, G.P.1
Ullrich, K.2
Tannert, A.3
Unger, C.4
Habicht, G.5
Sauter, S.R.6
Hortschansky, P.7
Horn, U.8
Mollmann, U.9
Decker, M.10
Lehmann, J.11
Fandrich, M.12
-
85
-
-
12144261198
-
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses
-
Cordle, A. and Landreth, G. (2005) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. J. Neurosci. 25, 299-307.
-
(2005)
J. Neurosci
, vol.25
, pp. 299-307
-
-
Cordle, A.1
Landreth, G.2
-
86
-
-
0345275964
-
Association of aortic atherosclerosis with cerebral beta amyloidosis and learning defects in a mouse model of Alzheimer's disease
-
Li, L., Cao, D., Garber, D.W., Kim, H., and Fukuchi, K. (2003) Association of aortic atherosclerosis with cerebral beta amyloidosis and learning defects in a mouse model of Alzheimer's disease. Am. J. Pathol. 163, 2155-2164.
-
(2003)
Am. J. Pathol
, vol.163
, pp. 2155-2164
-
-
Li, L.1
Cao, D.2
Garber, D.W.3
Kim, H.4
Fukuchi, K.5
-
87
-
-
0033833354
-
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
-
Refolo, L.M., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G.S., Sambamurthi, K., Duff, K., and Papolla, M.A. (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7, 321-331.
-
(2000)
Neurobiol. Dis
, vol.7
, pp. 321-331
-
-
Refolo, L.M.1
Malester, B.2
LaFrancois, J.3
Bryant-Thomas, T.4
Wang, R.5
Tint, G.S.6
Sambamurthi, K.7
Duff, K.8
Papolla, M.A.9
-
88
-
-
0029888944
-
Intraneuronal beta-amyloid immunoreactivity in the CNS
-
Sparks, D.L. (1996) Intraneuronal beta-amyloid immunoreactivity in the CNS. Neurobiol. Aging 17, 291-299.
-
(1996)
Neurobiol. Aging
, vol.17
, pp. 291-299
-
-
Sparks, D.L.1
-
89
-
-
68149148938
-
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice
-
Tong, X.K., Nicolakakis, N., Fernandes, P., Ongali, B., Brouillette, J., Quirion, R., and Hamel, E. (2009) Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol. Dis. 35, 406-414.
-
(2009)
Neurobiol. Dis
, vol.35
, pp. 406-414
-
-
Tong, X.K.1
Nicolakakis, N.2
Fernandes, P.3
Ongali, B.4
Brouillette, J.5
Quirion, R.6
Hamel, E.7
-
90
-
-
33846048569
-
Simvastatin enhances learning and memory independent of amyloid load in mice
-
Li, L., Cao, D., Kim, H., Lester, R., and Fukuchi, K. (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann. Neurol. 60, 729-739.
-
(2006)
Ann. Neurol
, vol.60
, pp. 729-739
-
-
Li, L.1
Cao, D.2
Kim, H.3
Lester, R.4
Fukuchi, K.5
-
91
-
-
0041382978
-
Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice
-
Park, I.H., Hwang, E.M., Hong, H.S., Boo, J.H., Oh, S.S., Lee, J., Jung, M.W., Bang, O.Y., Kim, S.U., and Mook-Jung, I. (2003) Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol. Aging 24, 637-643.
-
(2003)
Neurobiol. Aging
, vol.24
, pp. 637-643
-
-
Park, I.H.1
Hwang, E.M.2
Hong, H.S.3
Boo, J.H.4
Oh, S.S.5
Lee, J.6
Jung, M.W.7
Bang, O.Y.8
Kim, S.U.9
Mook-Jung, I.10
-
92
-
-
4644308807
-
Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain
-
Chauhan, N.B., Siegel, G.J., and Feinstein, D.L. (2004) Effects of lovastatin and pravastatin on amyloid processing and inflammatory response in TgCRND8 brain. Neurochem. Res. 29, 1897-1911.
-
(2004)
Neurochem. Res
, vol.29
, pp. 1897-1911
-
-
Chauhan, N.B.1
Siegel, G.J.2
Feinstein, D.L.3
-
93
-
-
65349152565
-
Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy
-
Boimel, M., Grigoriadis, N., Lourbopoulos, A., Touloumi, O., Rosenmann, D., Abramsky, O., and Rosenmann, H. (2009) Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. J. Neuropathol. Exp. Neurol. 68, 314-325.
-
(2009)
J. Neuropathol. Exp. Neurol
, vol.68
, pp. 314-325
-
-
Boimel, M.1
Grigoriadis, N.2
Lourbopoulos, A.3
Touloumi, O.4
Rosenmann, D.5
Abramsky, O.6
Rosenmann, H.7
-
94
-
-
0035897938
-
Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study
-
Kivipelto, M., Helkala, E.L., Laakso, M.P., Hänninen, T., Hallikainen, M., Alhainen, K., Soininen, H., Tuomilehto, J., and Nissinen, A. (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322, 1447-1451.
-
(2001)
BMJ
, vol.322
, pp. 1447-1451
-
-
Kivipelto, M.1
Helkala, E.L.2
Laakso, M.P.3
Hänninen, T.4
Hallikainen, M.5
Alhainen, K.6
Soininen, H.7
Tuomilehto, J.8
Nissinen, A.9
-
95
-
-
0031976318
-
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease
-
Notkola, I.L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm. C., Kivinen, P., Tuomilehto, J., and Nissinen, A. (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17, 14-20.
-
(1998)
Neuroepidemiology
, vol.17
, pp. 14-20
-
-
Notkola, I.L.1
Sulkava, R.2
Pekkanen, J.3
Erkinjuntti, T.4
Ehnholm, C.5
Kivinen, P.6
Tuomilehto, J.7
Nissinen, A.8
-
96
-
-
48649110601
-
Cholesterol as a risk factor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis
-
Anstey, K.J., Lipnicki, D.M., and Low, L.F. (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am. J. Geriatr. Psychiatry 16, 343-354.
-
(2008)
Am. J. Geriatr. Psychiatry
, vol.16
, pp. 343-354
-
-
Anstey, K.J.1
Lipnicki, D.M.2
Low, L.F.3
-
97
-
-
0035940542
-
Cholesterol and neuropathologic markers of AD: A population-based autopsy study
-
Launer, L.J., White, L.R., Petrovitch, H., Ross, G.W., and Curb, J.D. (2001) Cholesterol and neuropathologic markers of AD: a population-based autopsy study. Neurology 57, 1447-1452.
-
(2001)
Neurology
, vol.57
, pp. 1447-1452
-
-
Launer, L.J.1
White, L.R.2
Petrovitch, H.3
Ross, G.W.4
Curb, J.D.5
-
98
-
-
0032573572
-
Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels
-
Kuo, Y.M., Emmerling, M.R., Bisgaier, C.L., Essenburg, A.D., Lampert, H.C., Drumm, D., and Roher, A.E. (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem. Biophys. Res. Commun. 252, 711-715.
-
(1998)
Biochem. Biophys. Res. Commun
, vol.252
, pp. 711-715
-
-
Kuo, Y.M.1
Emmerling, M.R.2
Bisgaier, C.L.3
Essenburg, A.D.4
Lampert, H.C.5
Drumm, D.6
Roher, A.E.7
-
99
-
-
0037992873
-
Plasma total cholesterol level as a risk factor for Alzheimer disease. The Framingham study
-
Tan, Z.S., Seshadri, S., Beiser, A., Wilson, P.W., Kiel, D.P., Tocco, M., D'Agostino, R.B., and Wolf, P.A. (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease. The Framingham study. Arch. Intern. Med. 163, 1053-1057.
-
(2003)
Arch. Intern. Med
, vol.163
, pp. 1053-1057
-
-
Tan, Z.S.1
Seshadri, S.2
Beiser, A.3
Wilson, P.W.4
Kiel, D.P.5
Tocco, M.6
D'Agostino, R.B.7
Wolf, P.A.8
-
100
-
-
26444569232
-
Serum cholesterol and risk of Alzheimer's disease
-
Li, G., Shofer, J.B., Kukull, W.A., Peskind, E.R., Tsuang, D.W., Breitner, J.C., McCormick, W., Bowen, J.D., Teri, L., Schellenberg, G.D., and Larson, E.B. (2005) Serum cholesterol and risk of Alzheimer's disease. Neurology 65, 1045-1050.
-
(2005)
Neurology
, vol.65
, pp. 1045-1050
-
-
Li, G.1
Shofer, J.B.2
Kukull, W.A.3
Peskind, E.R.4
Tsuang, D.W.5
Breitner, J.C.6
McCormick, W.7
Bowen, J.D.8
Teri, L.9
Schellenberg, G.D.10
Larson, E.B.11
-
101
-
-
33745741303
-
Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease
-
Rockwood, K. (2006) Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol. Scand. Suppl. 185, 71-77.
-
(2006)
Acta Neurol. Scand. Suppl
, vol.185
, pp. 71-77
-
-
Rockwood, K.1
-
102
-
-
58249089520
-
Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study
-
Haag, M.D., Hofman, A., Koudstaal, P.J., Stricker, B.H., and Breteler, M.M. (2009) Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J. Neurol. Neurosurg. Psychiatry 80, 13-17.
-
(2009)
J. Neurol. Neurosurg. Psychiatry
, vol.80
, pp. 13-17
-
-
Haag, M.D.1
Hofman, A.2
Koudstaal, P.J.3
Stricker, B.H.4
Breteler, M.M.5
-
103
-
-
48749096049
-
Reduced risk of incident AD with elective statin use in a clinical trial cohort
-
Sparks, D.L., Kryscio, R.J., Sabbagh, M.N., Connor, D.J., Sparks, L.M., and Liebsack, C. (2008) Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr. Alzheimer Res. 5, 416-421.
-
(2008)
Curr. Alzheimer Res
, vol.5
, pp. 416-421
-
-
Sparks, D.L.1
Kryscio, R.J.2
Sabbagh, M.N.3
Connor, D.J.4
Sparks, L.M.5
Liebsack, C.6
-
104
-
-
0034638746
-
Statins and the risk of dementia
-
Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S., and Drachman, D.A. (2000) Statins and the risk of dementia. Lancet 356, 1627-1631.
-
(2000)
Lancet
, vol.356
, pp. 1627-1631
-
-
Jick, H.1
Zornberg, G.L.2
Jick, S.S.3
Seshadri, S.4
Drachman, D.A.5
-
105
-
-
34848835187
-
Statins reduce amyloid-beta production through inhibition of protein isoprenylation
-
Ostrowski, S.M., Wilkinson, B.L., Golde, T.E., and Landreth, G. (2007) Statins reduce amyloid-beta production through inhibition of protein isoprenylation. J. Biol. Chem. 282, 26832-26844.
-
(2007)
J. Biol. Chem
, vol.282
, pp. 26832-26844
-
-
Ostrowski, S.M.1
Wilkinson, B.L.2
Golde, T.E.3
Landreth, G.4
-
106
-
-
42549102658
-
Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts
-
Won, J.S., Im, Y.B., Khan, M., Contreras, M., Singh, A.K., and Singh, I. (2008) Lovastatin inhibits amyloid precursor protein (APP) beta-cleavage through reduction of APP distribution in Lubrol WX extractable low density lipid rafts. J. Neurochem. 105, 1536-1549.
-
(2008)
J. Neurochem
, vol.105
, pp. 1536-1549
-
-
Won, J.S.1
Im, Y.B.2
Khan, M.3
Contreras, M.4
Singh, A.K.5
Singh, I.6
-
107
-
-
38049173483
-
Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma
-
Zhou, Y., Suram, A., Venugopal, C., Prakasam, A., Lin, S., Su, Y., Li, B., Paul, S.M., and Sambamurti, K. (2008) Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. FASEB J. 22, 47-54.
-
(2008)
FASEB J
, vol.22
, pp. 47-54
-
-
Zhou, Y.1
Suram, A.2
Venugopal, C.3
Prakasam, A.4
Lin, S.5
Su, Y.6
Li, B.7
Paul, S.M.8
Sambamurti, K.9
-
108
-
-
21444445440
-
Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism
-
Cole, S.L., Grudzien, A., Manhart, I.O., Kelly, B.L., Oakley, H., and Vassar, R. (2005) Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. J. Biol. Chem. 280, 18755-18770.
-
(2005)
J. Biol. Chem
, vol.280
, pp. 18755-18770
-
-
Cole, S.L.1
Grudzien, A.2
Manhart, I.O.3
Kelly, B.L.4
Oakley, H.5
Vassar, R.6
-
109
-
-
15744397372
-
Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK
-
Pedrini, S., Carter, T.L., Prendergast, G., Petanceska, S., Ehrlich, M.E., and Gandy, S. (2005) Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. PLoS Med. 2, e18.
-
(2005)
PLoS Med
, vol.2
-
-
Pedrini, S.1
Carter, T.L.2
Prendergast, G.3
Petanceska, S.4
Ehrlich, M.E.5
Gandy, S.6
-
110
-
-
70349090597
-
Statins for the prevention of dementia
-
CD003160
-
McGuinness, B., Craig, D., Bullock, R., and Passmore, P. (2009) Statins for the prevention of dementia. Cochrane Database Syst. Rev. 2, CD003160.
-
(2009)
Cochrane Database Syst. Rev
, vol.2
-
-
McGuinness, B.1
Craig, D.2
Bullock, R.3
Passmore, P.4
-
111
-
-
43249094747
-
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
-
Arvanitakis, Z., Schneider, J.A., Wilson, R.S., Bienias, J.L., Kelly, J.F., Evans, D.A., and Bennett, D.A. (2008) Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70, 1795-1802.
-
(2008)
Neurology
, vol.70
, pp. 1795-1802
-
-
Arvanitakis, Z.1
Schneider, J.A.2
Wilson, R.S.3
Bienias, J.L.4
Kelly, J.F.5
Evans, D.A.6
Bennett, D.A.7
-
112
-
-
40649086183
-
-
Jones, R.W., Kivipelto, M., Feldman, H., Sparks, L., Doody, R., Waters, D.D., Hey-Hadavi, J., Breazna, A., Schindler, R.J., Ramos, H., and LEADe investigators. (2008) The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 4, 145-153.
-
Jones, R.W., Kivipelto, M., Feldman, H., Sparks, L., Doody, R., Waters, D.D., Hey-Hadavi, J., Breazna, A., Schindler, R.J., Ramos, H., and LEADe investigators. (2008) The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. Alzheimers Dement. 4, 145-153.
-
-
-
-
113
-
-
66349112615
-
Cholesterol-modifying strategies for Alzheimer's disease
-
Solomon, A. and Kivipelto, M. (2009) Cholesterol-modifying strategies for Alzheimer's disease. Expert Rev. Neurother. 9, 695-709.
-
(2009)
Expert Rev. Neurother
, vol.9
, pp. 695-709
-
-
Solomon, A.1
Kivipelto, M.2
-
115
-
-
58349109631
-
The Atorvastatin/Donepezil in Alzheimer's Disease (LEADe) study: Effect of atorvastatin on Alzheimer's disease progression by ApoE4 genotype
-
Presented at the, Chicago, IL, USA, 26-31 July Abstract
-
Sparks, D.L., Kivipelto, M., Doody, R., et al. (2008) The Atorvastatin/Donepezil in Alzheimer's Disease (LEADe) study: effect of atorvastatin on Alzheimer's disease progression by ApoE4 genotype. Presented at the Alzheimer's Association International Conference on Alzheimer's Disease. Chicago, IL, USA, 26-31 July (Abstract).
-
(2008)
Alzheimer's Association International Conference on Alzheimer's Disease
-
-
Sparks, D.L.1
Kivipelto, M.2
Doody, R.3
-
116
-
-
67650427264
-
Multi-center, randomized, double-blind, placebo-controlled trial of simvastatin to slow the progression of Alzheimer's disease
-
Presented at the, Chicago, IL, USA, 26-31 July Abstract T200
-
Sano, M. (2008) Multi-center, randomized, double-blind, placebo-controlled trial of simvastatin to slow the progression of Alzheimer's disease. Presented at the Alzheimer's Association International Conference on Alzheimer's Disease. Chicago, IL, USA, 26-31 July (Abstract T200).
-
(2008)
Alzheimer's Association International Conference on Alzheimer's Disease
-
-
Sano, M.1
-
117
-
-
0032716264
-
The antithrombotic effects of statins
-
Kearney, D. and Fitzgerald, D. (1999) The antithrombotic effects of statins. J. Am. Coll. Cardiol. 33, 1305-1307.
-
(1999)
J. Am. Coll. Cardiol
, vol.33
, pp. 1305-1307
-
-
Kearney, D.1
Fitzgerald, D.2
-
118
-
-
0035826856
-
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation
-
Undas, A., Brummel, K.E., Musial, J., Mann, K.G., and Szczeklik, A. (2001) Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation 103, 2248-2253.
-
(2001)
Circulation
, vol.103
, pp. 2248-2253
-
-
Undas, A.1
Brummel, K.E.2
Musial, J.3
Mann, K.G.4
Szczeklik, A.5
-
119
-
-
21544464772
-
Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients
-
Undas, A., Celinska-Lowenhoff, M., Brummel-Ziedins, K.E., Brozek, J., Szczeklik, A., and Mann, K.G. (2005) Simvastatin given for 3 days can inhibit thrombin generation and activation of factor V and enhance factor Va inactivation in hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 25, 1524-1525.
-
(2005)
Arterioscler. Thromb. Vasc. Biol
, vol.25
, pp. 1524-1525
-
-
Undas, A.1
Celinska-Lowenhoff, M.2
Brummel-Ziedins, K.E.3
Brozek, J.4
Szczeklik, A.5
Mann, K.G.6
-
120
-
-
0033786331
-
Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study
-
Lowe, G., Rumley, A., Norrie, J., Ford, I., Shepherd, J., Cobbe, S., Macfarlane, P., and Packard, C. (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb. Haemost. 84, 553-558.
-
(2000)
Thromb. Haemost
, vol.84
, pp. 553-558
-
-
Lowe, G.1
Rumley, A.2
Norrie, J.3
Ford, I.4
Shepherd, J.5
Cobbe, S.6
Macfarlane, P.7
Packard, C.8
-
121
-
-
21244483036
-
The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients
-
Muravyov, A.V., Yakusevich, V.V., Surovaya, L., and Petrochenko, A. (2004) The effect of simvastatin therapy on hemorheological profile in coronary heart desease (CHD) patients. Clin. Hemorheol. Microcirc. 31, 251-256.
-
(2004)
Clin. Hemorheol. Microcirc
, vol.31
, pp. 251-256
-
-
Muravyov, A.V.1
Yakusevich, V.V.2
Surovaya, L.3
Petrochenko, A.4
-
122
-
-
33745956809
-
-
Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D., Culebras, A., DeGraba, T.J., Gorelick, P.B., Guyton, J.R., Hart, R.G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R.L., and American Heart Association; American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113, e873-923.
-
Goldstein, L.B., Adams, R., Alberts, M.J., Appel, L.J., Brass, L.M., Bushnell, C.D., Culebras, A., DeGraba, T.J., Gorelick, P.B., Guyton, J.R., Hart, R.G., Howard, G., Kelly-Hayes, M., Nixon, J.V., Sacco, R.L., and American Heart Association; American Stroke Association Stroke Council (2006) Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 113, e873-923.
-
-
-
-
123
-
-
64549160555
-
Endothelial dysfunction in lacunar stroke: A systematic review
-
Knottnerus, I.L., Ten Cate, H., Lodder, J., Kessels, F., and van Oostenbrugge, R.J. (2009) Endothelial dysfunction in lacunar stroke: a systematic review. Cerebrovasc. Dis. 27, 519-526.
-
(2009)
Cerebrovasc. Dis
, vol.27
, pp. 519-526
-
-
Knottnerus, I.L.1
Ten Cate, H.2
Lodder, J.3
Kessels, F.4
van Oostenbrugge, R.J.5
-
124
-
-
67649218740
-
Endothelial function in lacunar infarction: A comparison of lacunar infarction, cerebral atherosclerosis and control group
-
Kim, J.S., Lee, H.S., Park, H.Y., Kim, S.S., Kang, H.G., Kim, N.H., Park, J.S., and Kim, Y. (2009) Endothelial function in lacunar infarction: a comparison of lacunar infarction, cerebral atherosclerosis and control group. Cerebrovasc. Dis. 28, 166-170.
-
(2009)
Cerebrovasc. Dis
, vol.28
, pp. 166-170
-
-
Kim, J.S.1
Lee, H.S.2
Park, H.Y.3
Kim, S.S.4
Kang, H.G.5
Kim, N.H.6
Park, J.S.7
Kim, Y.8
-
126
-
-
0004082267
-
-
3rd ed. Churchill Livingstone, New York
-
Barnett, H.J.M., Mohr, J.P., Stein, B.M., and Yatsu, F.M. (1998) Stroke: Pathophysiology, Diagnosis, and Management. 3rd ed. Churchill Livingstone, New York.
-
(1998)
Stroke: Pathophysiology, Diagnosis, and Management
-
-
Barnett, H.J.M.1
Mohr, J.P.2
Stein, B.M.3
Yatsu, F.M.4
-
127
-
-
63349102871
-
Classification of stroke subtypes
-
Amarenco, P., Bogousslavsky, J., Caplan, L.R., Donnan, G.A., and Hennerici, M.G. (2009) Classification of stroke subtypes. Cerebrovasc. Dis. 27, 493-501.
-
(2009)
Cerebrovasc. Dis
, vol.27
, pp. 493-501
-
-
Amarenco, P.1
Bogousslavsky, J.2
Caplan, L.R.3
Donnan, G.A.4
Hennerici, M.G.5
-
128
-
-
0343102318
-
Old cerebral hemorrhages in cases of multiple lacunar infarction found by magnetic resonance imaging
-
Miyashita, K., Naritomi, H., Nakamura, M., Kazui, S., and Sawada, T. (1991) Old cerebral hemorrhages in cases of multiple lacunar infarction found by magnetic resonance imaging. Cerebrovasc. Dis. 1, 321-326.
-
(1991)
Cerebrovasc. Dis
, vol.1
, pp. 321-326
-
-
Miyashita, K.1
Naritomi, H.2
Nakamura, M.3
Kazui, S.4
Sawada, T.5
-
129
-
-
0033766844
-
Frequency and location of microbleeds in patients with primary intracerebral hemorrhage
-
Roob, G., Lechner, A., Schmidt, R., Flooh, E., Hartung, H.P., and Fazekas, F. (2000) Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 31, 2665-2669.
-
(2000)
Stroke
, vol.31
, pp. 2665-2669
-
-
Roob, G.1
Lechner, A.2
Schmidt, R.3
Flooh, E.4
Hartung, H.P.5
Fazekas, F.6
-
130
-
-
33847184208
-
Lacunar infarct or deep intracerebral hemorrhage, who gets which? The Northern Manhattan Study
-
Labovitz, D.L., Boden-Albala, B., Hauser, W.A., and Sacco, R.L. (2007) Lacunar infarct or deep intracerebral hemorrhage, who gets which? The Northern Manhattan Study. Neurology 68, 606-608.
-
(2007)
Neurology
, vol.68
, pp. 606-608
-
-
Labovitz, D.L.1
Boden-Albala, B.2
Hauser, W.A.3
Sacco, R.L.4
-
131
-
-
0343273397
-
Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration
-
Anon
-
Anon. (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 346, 1647-1653.
-
(1995)
Lancet
, vol.346
, pp. 1647-1653
-
-
-
132
-
-
0037335782
-
Plasma lipid profile and incident ischemic stroke: The Atherosclerosis Risk in Communities (ARIC) study
-
Shahar, E., Chambless, L.E., Rosamond, W.D., Boland, L.L., Ballantyne, C.M., McGovern, P.G., and Sharrett, A.R. (2003) Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 34, 623-631.
-
(2003)
Stroke
, vol.34
, pp. 623-631
-
-
Shahar, E.1
Chambless, L.E.2
Rosamond, W.D.3
Boland, L.L.4
Ballantyne, C.M.5
McGovern, P.G.6
Sharrett, A.R.7
-
133
-
-
33847204608
-
Lipid levels and the risk of ischemic stroke in women
-
Kurth, T., Everett, B.M., Buring, J.E., Kase, C.S., Ridker, P.M., and Gaziano, J.M. (2007) Lipid levels and the risk of ischemic stroke in women. Neurology 68, 556-562.
-
(2007)
Neurology
, vol.68
, pp. 556-562
-
-
Kurth, T.1
Everett, B.M.2
Buring, J.E.3
Kase, C.S.4
Ridker, P.M.5
Gaziano, J.M.6
-
134
-
-
8844249957
-
Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups
-
Tirschwell, D.L., Smith, N.L., Heckbert, S.R., Lemaitre, R.N., Longstreth, W.T. Jr., and Psaty, B.M. (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63, 1868-1875.
-
(2004)
Neurology
, vol.63
, pp. 1868-1875
-
-
Tirschwell, D.L.1
Smith, N.L.2
Heckbert, S.R.3
Lemaitre, R.N.4
Longstreth Jr., W.T.5
Psaty, B.M.6
-
135
-
-
56349149980
-
HDL-C and LDL-C: Their role in stroke pathogenesis and implications for treatment
-
Sanossian, N. and Tarlov, N.E. (2008) HDL-C and LDL-C: their role in stroke pathogenesis and implications for treatment. Curr. Treat. Options Cardiovasc. Med. 10, 195-206.
-
(2008)
Curr. Treat. Options Cardiovasc. Med
, vol.10
, pp. 195-206
-
-
Sanossian, N.1
Tarlov, N.E.2
-
136
-
-
3242740195
-
High density lipoprotein cholesterol and the risk of stroke in elderly men: The Honolulu heart program
-
Curb, J.D., Abbott, R.D., Rodriguez, B.L., Masaki, K.H., Chen, R., Popper, J.S., Petrovitch, H., Ross, G.W., Schatz, I.J., Belleau, G.C., and Yano, K. (2004) High density lipoprotein cholesterol and the risk of stroke in elderly men: the Honolulu heart program. Am. J. Epidemiol. 160, 150-157.
-
(2004)
Am. J. Epidemiol
, vol.160
, pp. 150-157
-
-
Curb, J.D.1
Abbott, R.D.2
Rodriguez, B.L.3
Masaki, K.H.4
Chen, R.5
Popper, J.S.6
Petrovitch, H.7
Ross, G.W.8
Schatz, I.J.9
Belleau, G.C.10
Yano, K.11
-
137
-
-
0035816031
-
High-density lipoprotein cholesterol and ischemic stroke in the elderly: The Northern Manhattan Stroke Study
-
Sacco, R.L., Benson, R.T., Kargman, D.E., Boden-Albala. B., Tuck, C., Lin, I.F., Cheng, J.F., Paik, M.C., Shea, S., and Berglund, L. (2001) High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 285, 2729-2735.
-
(2001)
JAMA
, vol.285
, pp. 2729-2735
-
-
Sacco, R.L.1
Benson, R.T.2
Kargman, D.E.3
Boden-Albala, B.4
Tuck, C.5
Lin, I.F.6
Cheng, J.F.7
Paik, M.C.8
Shea, S.9
Berglund, L.10
-
138
-
-
0026558610
-
Lipids and risk of coronary heart disease. The Framingham Study
-
Castelli, W.P., Anderson, K., Wilson, P.W., and Levy, D. (1992) Lipids and risk of coronary heart disease. The Framingham Study. Ann. Epidemiol. 2, 23-28.
-
(1992)
Ann. Epidemiol
, vol.2
, pp. 23-28
-
-
Castelli, W.P.1
Anderson, K.2
Wilson, P.W.3
Levy, D.4
-
139
-
-
0036156461
-
Total and HDL cholesterol and risk of stroke. EUROSTROKE: A collaborative study among research centres in Europe
-
Bots, M.L., Elwood, P.C., Nikitin, Y., Salonen, J.T., Freire, de Concalves, A., Inzitari, D., Sivenius, J., Benetou, V., Tuomilehto, J., Koudstaal, P.J., and Grobbee, D.E. (2002) Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J. Epidemiol. Community Health 56, i19-i24.
-
(2002)
J. Epidemiol. Community Health
, vol.56
-
-
Bots, M.L.1
Elwood, P.C.2
Nikitin, Y.3
Salonen, J.T.4
Freire5
de Concalves, A.6
Inzitari, D.7
Sivenius, J.8
Benetou, V.9
Tuomilehto, J.10
Koudstaal, P.J.11
Grobbee, D.E.12
-
140
-
-
0030840078
-
Prognostic value of cholesterol in women of different ages
-
Emond, M.J. and Zareba, W. (1997) Prognostic value of cholesterol in women of different ages. J. Womens Health 6, 295-307.
-
(1997)
J. Womens Health
, vol.6
, pp. 295-307
-
-
Emond, M.J.1
Zareba, W.2
-
141
-
-
12844262139
-
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study
-
McNeill, A.M., Schmidt, M.I., Rosamond, W.D., East, H.E., Girman, C.J., Ballantyne, C.M., Golden, S.H., and Heiss, G. (2005) The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28, 385-390.
-
(2005)
Diabetes Care
, vol.28
, pp. 385-390
-
-
McNeill, A.M.1
Schmidt, M.I.2
Rosamond, W.D.3
East, H.E.4
Girman, C.J.5
Ballantyne, C.M.6
Golden, S.H.7
Heiss, G.8
-
142
-
-
0024519925
-
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factors International Trial
-
Iso, H., Jacobs, D.R., Jr., Wentworth, D., Neaton, J.D., and Cohen, J.D. (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factors International Trial. N. Engl. J. Med. 320, 904-910.
-
(1989)
N. Engl. J. Med
, vol.320
, pp. 904-910
-
-
Iso, H.1
Jacobs Jr., D.R.2
Wentworth, D.3
Neaton, J.D.4
Cohen, J.D.5
-
143
-
-
3042597838
-
Animal protein, animal fat, and cholesterol intakes and risk of cerebral infarction mortality in the adult health study
-
Sauvaget, C., Nagano, J., Hayashi, M., and Yamada, M. (2004) Animal protein, animal fat, and cholesterol intakes and risk of cerebral infarction mortality in the adult health study. Stroke 35, 1531-1537.
-
(2004)
Stroke
, vol.35
, pp. 1531-1537
-
-
Sauvaget, C.1
Nagano, J.2
Hayashi, M.3
Yamada, M.4
-
144
-
-
0029808431
-
Low total serum cholesterol and intracerebral hemorrhagic stroke: Is the association confined to elderly men? The Kaiser Permanente Medical Care Program
-
Iribarren, C., Jacobs, D.R., Sadler, M., Claxton, A.J., and Sidney, S. (1996) Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 27, 1993-1998.
-
(1996)
Stroke
, vol.27
, pp. 1993-1998
-
-
Iribarren, C.1
Jacobs, D.R.2
Sadler, M.3
Claxton, A.J.4
Sidney, S.5
-
145
-
-
0027273801
-
Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women
-
Gatchev, O., Rastam, L., Lindberg, G., Gullberg, B., Eklund, G.A., and Isacsson, S.O. (1993) Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. Ann. Epidemiol. 3, 403-409.
-
(1993)
Ann. Epidemiol
, vol.3
, pp. 403-409
-
-
Gatchev, O.1
Rastam, L.2
Lindberg, G.3
Gullberg, B.4
Eklund, G.A.5
Isacsson, S.O.6
-
146
-
-
22544457919
-
Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality
-
Elkind, M.S., Flint, A.C., Sciacca, R.R., and Sacco, R.L. (2005) Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology. 65, 253-258.
-
(2005)
Neurology
, vol.65
, pp. 253-258
-
-
Elkind, M.S.1
Flint, A.C.2
Sciacca, R.R.3
Sacco, R.L.4
-
147
-
-
2642547998
-
Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events
-
Greisenegger, S., Müllner, M., Tentschert, S., Lang, W., and Lalouschek, W. (2004) Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J. Neurol. Sci. 221, 5-10.
-
(2004)
J. Neurol. Sci
, vol.221
, pp. 5-10
-
-
Greisenegger, S.1
Müllner, M.2
Tentschert, S.3
Lang, W.4
Lalouschek, W.5
-
148
-
-
4143083577
-
Prior statin therapy is associated with a decreased rate of severe sepsis
-
Almog, Y., Shefer, A., Novack, V., Maimon, N., Barski, L., Eizinger, M., Friger, M., Zeller, L., and Danon, A. (2004) Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 110, 880-885.
-
(2004)
Circulation
, vol.110
, pp. 880-885
-
-
Almog, Y.1
Shefer, A.2
Novack, V.3
Maimon, N.4
Barski, L.5
Eizinger, M.6
Friger, M.7
Zeller, L.8
Danon, A.9
-
149
-
-
11144357096
-
Favorable outcome of ischemic stroke in patients pretreated with statins
-
Marti-Fabregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvis, R., Cocho, D., Roquer, J., Rodriguez, A., Garcia, M.D., Molina-Porcel, L., Diaz-Manera, J., and Marti-Vilalta, J.L. (2004) Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 35, 1117-1121.
-
(2004)
Stroke
, vol.35
, pp. 1117-1121
-
-
Marti-Fabregas, J.1
Gomis, M.2
Arboix, A.3
Aleu, A.4
Pagonabarraga, J.5
Belvis, R.6
Cocho, D.7
Roquer, J.8
Rodriguez, A.9
Garcia, M.D.10
Molina-Porcel, L.11
Diaz-Manera, J.12
Marti-Vilalta, J.L.13
-
150
-
-
0034648068
-
Acute inflammatory reaction following experimental intracerebral hemorrhage in rat
-
Gong, C., Hoff, J.T., and Keep, R.F. (2000) Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res. 871, 57-65.
-
(2000)
Brain Res
, vol.871
, pp. 57-65
-
-
Gong, C.1
Hoff, J.T.2
Keep, R.F.3
-
151
-
-
3042688440
-
HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage
-
Jung, K.H., Chu, K., Jeong, S.W., Han, S.Y., Lee, S.T., Kim, J.Y., Kim, M., and Roh, J.K. (2004) HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. Stroke 35, 1744-1749.
-
(2004)
Stroke
, vol.35
, pp. 1744-1749
-
-
Jung, K.H.1
Chu, K.2
Jeong, S.W.3
Han, S.Y.4
Lee, S.T.5
Kim, J.Y.6
Kim, M.7
Roh, J.K.8
-
152
-
-
0032555154
-
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
-
Endres, M., Laufs, U., Huang, Z., Nakamura, T., Huang, P., Moskowitz, M.A., and Liao, J.K. (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 95, 8880-8885.
-
(1998)
Proc. Natl. Acad. Sci. U. S. A
, vol.95
, pp. 8880-8885
-
-
Endres, M.1
Laufs, U.2
Huang, Z.3
Nakamura, T.4
Huang, P.5
Moskowitz, M.A.6
Liao, J.K.7
-
153
-
-
0000306390
-
Statins do more than just lower cholesterol
-
Vaughan, C.J., Murphy, M.D., and Buckley, B.M. (1996) Statins do more than just lower cholesterol. Lancet 348, 1079-1082.
-
(1996)
Lancet
, vol.348
, pp. 1079-1082
-
-
Vaughan, C.J.1
Murphy, M.D.2
Buckley, B.M.3
-
154
-
-
33746895436
-
High-dose atorvastatin after stroke or transient ischemic attack
-
Amarenco, P., Bogousslavsky, J., Callahan, A., III, Goldstein, L.B., Hennerici, M., Rudolph, A.E., Sillesen, H., Simunovic, L., Szarek, M., Welch, K.M., and Zivin, J.A. (2006) High-dose atorvastatin after stroke or transient ischemic attack. N. Engl. J. Med. 355, 549-559.
-
(2006)
N. Engl. J. Med
, vol.355
, pp. 549-559
-
-
Amarenco, P.1
Bogousslavsky, J.2
Callahan III, A.3
Goldstein, L.B.4
Hennerici, M.5
Rudolph, A.E.6
Sillesen, H.7
Simunovic, L.8
Szarek, M.9
Welch, K.M.10
Zivin, J.A.11
-
155
-
-
9444249842
-
Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis
-
Amarenco, P., Labreuche, J., Lavallee, P., and Touboul, P.J. (2004) Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35, 2902-2909.
-
(2004)
Stroke
, vol.35
, pp. 2902-2909
-
-
Amarenco, P.1
Labreuche, J.2
Lavallee, P.3
Touboul, P.J.4
-
156
-
-
67650094817
-
-
Leker, R.R., Khoury, S.T., Rafaeli, G., Shwartz, R., Eichel, R., Tanne, D.; on behalf of the NASIS Investigators. (2009) Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 40, 2581-2584.
-
Leker, R.R., Khoury, S.T., Rafaeli, G., Shwartz, R., Eichel, R., Tanne, D.; on behalf of the NASIS Investigators. (2009) Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 40, 2581-2584.
-
-
-
-
157
-
-
0035936503
-
Reduction of stroke events with pravastatin: The Prospective Pravastatin Pooling (PPP) Project
-
Byington, R.P., Davis, B.R., Plehn, J.F., White, H.D., Baker, J., Cobbe, S.M., and Shepherd, J. (2001) Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project. Circulation 103, 387-392.
-
(2001)
Circulation
, vol.103
, pp. 387-392
-
-
Byington, R.P.1
Davis, B.R.2
Plehn, J.F.3
White, H.D.4
Baker, J.5
Cobbe, S.M.6
Shepherd, J.7
-
158
-
-
65549117287
-
Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism
-
Kim, B.J., Lee, S.H., Ryu, W.S., Kang, B.S., Kim, C.K., and Yoon, B.W. (2009) Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 40, 1627-1632.
-
(2009)
Stroke
, vol.40
, pp. 1627-1632
-
-
Kim, B.J.1
Lee, S.H.2
Ryu, W.S.3
Kang, B.S.4
Kim, C.K.5
Yoon, B.W.6
-
159
-
-
2542641056
-
Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: A case-control study
-
Woo, D., Kissela, B.M., Khoury, J.C., Sauerbeck, L.R., Haverbusch, M.A., Szaflarski, J.P., Gebel, J.M., Pancioli, A.M., Jauch, E.C., Schneider, A., Kleindorfer, D., and Broderick, J.P. (2004) Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke 35, 1360-1364.
-
(2004)
Stroke
, vol.35
, pp. 1360-1364
-
-
Woo, D.1
Kissela, B.M.2
Khoury, J.C.3
Sauerbeck, L.R.4
Haverbusch, M.A.5
Szaflarski, J.P.6
Gebel, J.M.7
Pancioli, A.M.8
Jauch, E.C.9
Schneider, A.10
Kleindorfer, D.11
Broderick, J.P.12
-
160
-
-
0028901424
-
Effects of Apolipoprotein E and A-IV phenotypes on the low-density lipoprotein response to HMG CoA reductase inhibitor therapy
-
Ordovas, J.M., Lopez-Miranda, J., Perez-Jimenez, F., Rodriguez, C., Park, J.S., Cole, T., and Schaefer, E.J. (1995) Effects of Apolipoprotein E and A-IV phenotypes on the low-density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis 113, 157-166.
-
(1995)
Atherosclerosis
, vol.113
, pp. 157-166
-
-
Ordovas, J.M.1
Lopez-Miranda, J.2
Perez-Jimenez, F.3
Rodriguez, C.4
Park, J.S.5
Cole, T.6
Schaefer, E.J.7
-
161
-
-
33644700591
-
Risk factors for subarachnoid hemorrhage: An updated systematic review of epidemiological studies
-
Feigin, V.L., Rinkel, G.J., Lawes, C.M., Algra, A., Bennett, D.A., van Gijn, J., and Anderson, C.S. (2005) Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36, 2773-2780.
-
(2005)
Stroke
, vol.36
, pp. 2773-2780
-
-
Feigin, V.L.1
Rinkel, G.J.2
Lawes, C.M.3
Algra, A.4
Bennett, D.A.5
van Gijn, J.6
Anderson, C.S.7
-
162
-
-
0029878999
-
Risk factors for subarachnoid hemorrhage a systematic review
-
Teunissen, L., Rinkel, G., Algra, A., and van Gijn, J. (1996) Risk factors for subarachnoid hemorrhage a systematic review. Stroke 27, 544-549.
-
(1996)
Stroke
, vol.27
, pp. 544-549
-
-
Teunissen, L.1
Rinkel, G.2
Algra, A.3
van Gijn, J.4
-
163
-
-
33947517351
-
Cholesterol level and hemorrhagic transformation after ischemic stroke thrombolysis
-
Bang, O.Y., Saver, J.L., Liebeskind, D.S., Starkman, S., Villablanca, P., Salamon, N., Buck, B., Ali, L., Restrepo, L., Vinuela, F., Duckwiler, G., Jahan, R., Razinia, T., and Ovbiagele, B. (2007) Cholesterol level and hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 68, 737-742.
-
(2007)
Neurology
, vol.68
, pp. 737-742
-
-
Bang, O.Y.1
Saver, J.L.2
Liebeskind, D.S.3
Starkman, S.4
Villablanca, P.5
Salamon, N.6
Buck, B.7
Ali, L.8
Restrepo, L.9
Vinuela, F.10
Duckwiler, G.11
Jahan, R.12
Razinia, T.13
Ovbiagele, B.14
-
164
-
-
64149114758
-
Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome
-
Fuentes, B., Martínez-Sánchez, P., and Díez-Tejedor, E. (2009) Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Cerebrovasc. Dis. 27, 126-133.
-
(2009)
Cerebrovasc. Dis
, vol.27
, pp. 126-133
-
-
Fuentes, B.1
Martínez-Sánchez, P.2
Díez-Tejedor, E.3
-
165
-
-
47349088595
-
New targets of neuroprotection in ischemic stroke
-
Bacigaluppi, M. and Hermann, D.M. (2008) New targets of neuroprotection in ischemic stroke. TheScientificWorldJOURNAL 8, 698-712.
-
(2008)
TheScientificWorldJOURNAL
, vol.8
, pp. 698-712
-
-
Bacigaluppi, M.1
Hermann, D.M.2
-
166
-
-
34548278923
-
Statin treatment withdrawal in ischemic stroke: A controlled randomized study
-
Blanco, M., Nombela, F., Castellanos, M., Rodriguez-Yanez, M., Garcia-Gil, M., Leira, R., Lizasoain, I., Serena, J., Vivancos, J., Moro, M.A., Dávalos, A., and Castillo, J. (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69, 904-910.
-
(2007)
Neurology
, vol.69
, pp. 904-910
-
-
Blanco, M.1
Nombela, F.2
Castellanos, M.3
Rodriguez-Yanez, M.4
Garcia-Gil, M.5
Leira, R.6
Lizasoain, I.7
Serena, J.8
Vivancos, J.9
Moro, M.A.10
Dávalos, A.11
Castillo, J.12
|